SRS Timing With Immune Checkpoint Inhibition in Patients With Untreated Brain Metastases From Non-small Cell Lung Cancer

NCT04650490 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped failure to enroll

Conditions

Brain Metastases
Non Small Cell Lung Cancer

Interventions

RADIATION: Stereotactic Radiosurgery
DRUG: Immunotherapy

Sponsor

Duke University